Michael C. Haffner

9.6k citations

120 papers · 5.3k indexed · 1 hit paper · h-index 34

Impact in

Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment

Papers in

Pulmonary and Respiratory Medicine 79
- Prostate Cancer Treatment and Research 69
- Prostate Cancer Diagnosis and Treatment 29
Cancer Research 24
- Cancer Genomics and Diagnostics 10
- Cancer, Lipids, and Metabolism 9

Co-authors: Srinivasan Yegnasubramanian William G. Nelson Angelo M. De Marzo Alan K. Meeker David Esopi William B. Isaacs George J. Netto Antoun Toubaji
Journals: Journal of Clinical Oncology (11 papers)Cancer Research (9 papers)Clinical Cancer Research (7 papers)The Journal of Urology (6 papers)Human Pathology (5 papers)
Partner nations: United States Austria South Africa

In The Last Decade

Michael C. Haffner

115 papers receiving 5.3k citations

Hit Papers

align trajectories log scale

Genomic and phenotypic heterogeneity in prostate cancer 2020 · 307 citations

Peers

Countries citing papers authored by Michael C. Haffner

Since Specialization

Citations

This map shows the geographic impact of Michael C. Haffner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Haffner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Haffner more than expected).

Fields of papers citing papers by Michael C. Haffner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael C. Haffner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Haffner. The network helps show where Michael C. Haffner may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael C. Haffner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael C. Haffner Line = papers co-authored together Michael C. Haffner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A combinatorial genetic strategy for exploring complex genotype–phenotype associations in cancer Nature Genetics ·Shan Li, Alicia Y. W. Wong, 徐爽, Vipul Bhatia, Priyesh Gothwal, Seema Bhagowoti, Qian Wu, Bruce Montgomery, Jonathan L. Wright, Hung‐Ming Lam, Andrew C. Hsieh, Bishoy M. Faltas, Michael C. Haffner, John K. Lee	2024	6
2	Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to ¹⁷⁷Lu-PSMA-617: A Retrospective Multicenter Cohort Study JCO Precision Oncology ·Arkadii I Lipkin, George Mo, Invonne Suryana, Laura Graham, Roman Gulati, Colin C. Pritchard, Michael C. Haffner, Todd Yezefski, Jessica E. Hawley, Heather H. Cheng, Evan Y. Yu, Petros Grivas, Bruce Montgomery, Peter S. Nelson, Delphine L. Chen, Thomas A. Hope, Amir Iravani, Michael T. Schweizer	2024	7
3	SND1 binds to ERG and promotes tumor growth in genetic mouse models of prostate cancer Nature Communications ·M. Juny, Martin Miller, Sander B. Frank, Luan T. Phan, Olga Klezovitch, Julian Kwan, Ilsa M. Coleman, Michael C. Haffner, Dapei Li, Peter S. Nelson, Andrew Emili, Valeri Vasioukhin	2023	10
4	FASN Gene Methylation is Associated with Fatty Acid Synthase Expression and Clinical-genomic Features of Prostate Cancer Cancer Research Communications ·Jade Wu, 汤瑞琪, 池田学, Thiago Vidotto, Adrianna A. Mendes, Jiayun Lu, 韦元养, Jessica Hicks, Adam G. Sowalsky, Angelo M. De Marzo, Sheikh Sharfuddin Rajib, Brian Hanratty, Karen S. Sfanos, William B. Isaacs, Michael C. Haffner, Tamara L. Lotan	2023	2
5	Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer Clinical Cancer Research ·Ilsa M. Coleman, Navonil De Sarkar, Colm Morrissey, Xin Li, Martine P. Roudier, Fernanda M Cajú, Dapei Li, Eva Corey, Michael C. Haffner, Peter S. Nelson	2022	18
6	Elevated expression of the colony-stimulating factor 1 (CSF1) induces prostatic intraepithelial neoplasia dependent of epithelial-Gp130 Oncogene ·Oh‐Joon Kwon, Boyu Zhang, Deyong Jia, Li Zhang, Xing Wei, Zhicheng Zhou, Deli Liu, Kondasinghe Gayantha Nishan Thilawala, Kai Zhang, Vládia Geane Moura Silva, Paul Labhart, Andrea Sboner, Xiao Ling, Michael C. Haffner, Chad J. Creighton, Xin Li	2022	7
7	Comprehensive Assessment of Anaplastic Lymphoma Kinase in Localized and Metastatic Prostate Cancer Reveals Targetable Alterations Cancer Research Communications ·Radhika A. Patel, Ilsa Coleman, Martine P. Roudier, Eric Q. Konnick, Brian Hanratty, Ruth F. Dumpit, Jared M. Lucas, Lisa S. Ang, Jin‐Yih Low, Maria Tretiakova, Gavin Ha, John K. Lee, Lawrence D. True, Angelo M. De Marzo, Peter S. Nelson, Colm Morrissey, Colin C. Pritchard, Michael C. Haffner	2022	5
8	Oncogenic role of a developmentally regulated NTRK2 splice variant Science Advances ·Siobhan S. Pattwell, Sonali Arora, Mohammed Al-zharani, Michael Zager, Keith R. Loeb, Patrick J. Cimino, 晴子飯田, В. О. Япаскурт, Hamid Bolouri, Андрюнин Константин Маратович, Frank Szulzewsky, Vaishnavi V. Phadnis, Tatsuya Ozawa, Michael J. Wagner, Michael C. Haffner, Junyue Cao, Jay Shendure, Eric C. Holland	2022	3
9	RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer Cancer Research ·Mark P. Labrecque, Lisha G. Brown, Ilsa M. Coleman, Bryce Lakely, Nicholas J. Brady, John K. Lee, Holly M. Nguyen, Dapei Li, Brian Hanratty, Michael C. Haffner, David S. Rickman, Lawrence D. True, Daniel W. Lin, Hung‐Ming Lam, Joshi J. Alumkal, Eva Corey, Peter S. Nelson, Colm Morrissey	2021	23
10	Downregulation of 5‐hydroxymethylcytosine is an early event in pancreatic tumorigenesis The Journal of Pathology ·Kohei Fujikura, دارا طه, Michael C. Haffner, María A. Trujillo, Nicholas J. Roberts, Seung‐Mo Hong, Anne M. Macgregor‐Das, Michael Goggins, Sujayita Roy, Alan K. Meeker, Ding Ding, Michael Wright, Jin He, Ralph H. Hruban, Laura D. Wood	2021	12
11	Oncogenic gene fusions in nonneoplastic precursors as evidence that bacterial infection can initiate prostate cancer Proceedings of the National Academy of Sciences ·Eva Shrestha, Jonathan B. Coulter, Z.J. Dolatowski, Juan Manuel Estrada Jiménez, TAN HELONG, 正仁俵原, Sarah E. Ernst, Janielle P. Maynard, Alan K. Meeker, Christopher M. Heaphy, Michael C. Haffner, Angelo M. De Marzo, Karen S. Sfanos	2021	32
12	Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells Molecular Cancer Research ·Mindy K. Graham, Zehui Dong, С. А. Вырко, Jacqueline A. Brosnan‐Cashman, Anthony Rizzo, Javier Baena-Del Valle, Lionel Chia, M S Hidayat, Christine Davis, Qizhi Zheng, Leslie Cope, Michael Considine, Michael C. Haffner, Angelo M. De Marzo, Alan K. Meeker, Christopher M. Heaphy	2019	22
13	Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression Cancer Research ·Robert M. Hughes, Brian W. Simons, Dao-Ling Huang, Rebecca L. Miller, 孝一高志, Timary A. Bonaccorso, Debebe Theodros, Michael C. Haffner, Tamara L. Lotan, Jessie Huang, Elai Davicioni, Steven S. An, Ryan C. Riddle, Daniel L.J. Thorek, Isla P. Garraway, Elana J. Fertig, John T. Isaacs, W. Nathaniel Brennen, Ben Ho Park, Paula J. Hurley	2019	52
14	Analytic, Preanalytic, and Clinical Validation of p53 IHC for Detection of TP53 Missense Mutation in Prostate Cancer Clinical Cancer Research ·Liana B. Guedes, Fawaz Almutairi, Michael C. Haffner, А С Лебедев, Zach Liu, Danilo Yuzo [UNESP] Nishimoto, Samantha Késsya Souza Pinheiro, Kasra Yousefi, Rajni Sharma, Angelo M. De Marzo, George J. Netto, William B. Isaacs, Ashley E. Ross, Edward M. Schaeffer, Tamara L. Lotan	2017	62
15	Analytic Validation of RNA In Situ Hybridization (RISH) for AR and AR-V7 Expression in Human Prostate Cancer Clinical Cancer Research ·Liana B. Guedes, Carlos L. Morais, Fawaz Almutairi, Michael C. Haffner, Qizhi Zheng, John T. Isaacs, Emmanuel S. Antonarakis, Changxue Lu, Harrison Tsai, Jun Luo, Angelo M. De Marzo, Tamara L. Lotan	2016	25
16	Androgen Deprivation Followed by Acute Androgen Stimulation Selectively Sensitizes AR-Positive Prostate Cancer Cells to Ionizing Radiation Clinical Cancer Research ·Mohammad Hedayati, Michael C. Haffner, Jonathan B. Coulter, Raju R. Raval, Yonggang Zhang, Haoming Zhou, Omar Y. Mian, Emma Knight, M. de Reus, Susan L. Dalrymple, John T. Isaacs, 叶水涛, Russell K. Hales, William G. Nelson, Srinivasan Yegnasubramanian, Theodore L. DeWeese	2016	33
17	Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression Cancer Research ·Paula J. Hurley, Robert M. Hughes, Brian W. Simons, Jessie Huang, Rebecca M. Miller, Brian Shinder, Michael C. Haffner, David Esopi, Yasunori Kimura, Shiro Akatsu, Ashley E. Ross, Nicholas Erho, Ismael A. Vergara, Sheila F. Faraj, Elai Davicioni, George J. Netto, Srinivasan Yegnasubramanian, Steven S. An, Edward M. Schaeffer	2015	22
18	Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma Acta Neuropathologica Communications ·Sama Ahsan, Eric H. Raabe, Michael C. Haffner, Ajay Vaghasia, Katherine E. Warren, Martha Quezado, Leomar Y. Ballester, Javad Nazarian, Charles G. Eberhart, Fausto J. Rodríguez	2014	33
19	miR-21: An Androgen Receptor–Regulated MicroRNA that Promotes Hormone-Dependent and Hormone-Independent Prostate Cancer Growth Cancer Research ·Judit Ribas, Xiaohua Ni, Michael C. Haffner, Erik A. Wentzel, Amirali Salmasi, Wasim H. Chowdhury, Tarana A. Kudrolli, Srinivasan Yegnasubramanian, Jun Luo, Ron Rodriguez, Joshua T. Mendell, Shawn E. Lupold	2009	350
20	DNA Hypomethylation Arises Later in Prostate Cancer Progression than CpG Island Hypermethylation and Contributes to Metastatic Tumor Heterogeneity Cancer Research ·Srinivasan Yegnasubramanian, Michael C. Haffner, Yonggang Zhang, Bora Gürel, Toby C. Cornish, Zhijin Wu, Rafael A. Irizarry, James Morgan, Jessica Hicks, Theodore L. DeWeese, William B. Isaacs, G. Steven Bova, Angelo M. De Marzo, William G. Nelson	2008	214

About Michael C. Haffner

Michael C. Haffner is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 120 papers that have together received 5.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (69 papers), Prostate Cancer Diagnosis and Treatment (29 papers), Epigenetics and DNA Methylation (17 papers), Cancer-related gene regulation (15 papers), Radiopharmaceutical Chemistry and Applications (11 papers), PARP inhibition in cancer therapy (11 papers), Cancer Genomics and Diagnostics (10 papers) and Cancer, Lipids, and Metabolism (9 papers). The work is most often cited by research in Cancer Research (1.5k citations), Pulmonary and Respiratory Medicine (2.5k citations), Oncology (1.2k citations), Molecular Biology (2.8k citations) and Radiology, Nuclear Medicine and Imaging (464 citations). Michael C. Haffner has collaborated with scholars based in United States, Austria and South Africa. Frequent co-authors include Srinivasan Yegnasubramanian, William G. Nelson, Angelo M. De Marzo, Alan K. Meeker, David Esopi, William B. Isaacs, George J. Netto, Antoun Toubaji, Jonathan I. Epstein and Jessica Hicks. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, The Journal of Urology and Human Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact